As MPO is commonly activated in inflammatory responses, we postulated that induction of inflammation, and recruitment of myeloid cells with increased MPO activity, may provide a supportive BM microenvironment to promote MM tumour development and growth. The gene discussed is MPO; the disease is Miyoshi myopathy.